Insider · CIK 0001248190

CAPPS VICKIE L

Reports to the SEC for 10 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001248190

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2026-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+5,500 sh	—	—	79,598
2026-06-10	OFIXOrthofix Medical Inc.A Award	Director	AAward	+15K sh	—	—	43,300
2026-03-10	OFIXOrthofix Medical Inc.P Purchase	Director	PPurchase	+2,400 sh	$12.45	+$29.9K	27,585
2026-03-10	OFIXOrthofix Medical Inc.P Purchase	Director	PPurchase	+100 sh	$12.44	+$1,244	25,185
2026-03-09	OFIXOrthofix Medical Inc.P Purchase	Director	PPurchase	+2,500 sh	$12.48	+$31.2K	25,085
2025-08-14	AMEDISYS INCD Disposition to Issuer	Director	DDisposition to Issuer	−9,818 sh	—	—	0
2025-06-18	OFIXOrthofix Medical Inc.A Award	Director	AAward	+18.8K sh	—	—	21,934
2025-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+3,750 sh	—	—	74,098
2025-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.7K sh	—	—	11,667
2025-05-03	AMEDISYS INCA Award	Director	AAward	+1,690 sh	—	—	9,818
2025-03-11	OFIXOrthofix Medical Inc.A Award	Director	AAward	+3,093 sh	—	—	3,093
2025-03-11	OFIXOrthofix Medical Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+35.3K sh	—	—	35,270
2024-11-05	JANXJanux Therapeutics, Inc.J Other	Director	JOther	+2,305 sh	—	—	70,348
2024-06-26	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,350 sh	—	—	8,350
2024-06-26	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+2,500 sh	—	—	68,043
2024-05-03	AMEDISYS INCA Award	Director	AAward	+1,678 sh	—	—	8,128
2024-02-29	JANXJanux Therapeutics, Inc.J Other	Director	JOther	+1,493 sh	—	—	65,543
2023-09-01	NUVASIVE INCD Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−4,001 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,501 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,130 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,822 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,230 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,577 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,095 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,788 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−4,816 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,702 sh	—	—	0
2023-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-06-09	NUVASIVE INCRSUsA Award	Director	AAward	+4,816 sh	—	—	4,816
2023-05-03	AMEDISYS INCA Award	Director	AAward	+1,941 sh	—	—	6,450
2022-11-28	OTONOMY, INC.S Sale	Director	SSale	−42.2K sh	$0.10	−$4,342.478	3,400
2022-06-21	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2022-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2022-06-10	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-09	AMEDISYS INCA Award	Director	AAward	+1,304 sh	—	—	4,509
2022-05-11	NUVASIVE INCRSUsA Award	Director	AAward	+3,788 sh	—	—	3,788
2021-06-22	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-06-08	AMEDISYS INCA Award	Director	AAward	+574 sh	—	—	3,205
2021-06-04	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-05-18	NUVASIVE INCRSUsA Award	Director	AAward	+2,702 sh	—	—	2,702
2020-12-08	SPRYARS Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+9,523 sh	$21.00	+$200K	61,576
2020-12-03	SPRYARS Pharmaceuticals, Inc. · Employee Stock Option Right to BuyA Award	Director	AAward	+38.4K sh	—	—	38,405
2020-11-09	NUVASIVE INCP Purchase	Director	PPurchase	+2,000 sh	$48.23	+$96.5K	2,000
2020-06-23	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2020-06-09	AMEDISYS INCA Award	Director	AAward	+851 sh	—	—	2,631
2020-05-28	NUVASIVE INCRSUsA Award	Director	AAward	+3,095 sh	—	—	3,095
2020-02-25	AMEDISYS INCP Purchase	Director	PPurchase	+1,000 sh	$187.00	+$187K	1,780
2020-01-23	Synthorx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.3K sh	$55.60	−$853K	0

Recent filings

Accepted (ET)
Jun 124
CAPPS VICKIE L0001248190-26-000002
SEC(opens sec.gov)
Jun 124
CAPPS VICKIE L0001193125-26-269866
SEC(opens sec.gov)
Mar 104
CAPPS VICKIE L0001193125-26-100156
SEC(opens sec.gov)
Aug 144
CAPPS VICKIE L0000896262-25-000082
SEC(opens sec.gov)
Jun 234
CAPPS VICKIE L0000950170-25-088996
SEC(opens sec.gov)
Jun 134
CAPPS VICKIE L0001415889-25-017316
SEC(opens sec.gov)
May 64
CAPPS VICKIE L0000896262-25-000043
SEC(opens sec.gov)
Mar 134
CAPPS VICKIE L0000950170-25-038774
SEC(opens sec.gov)
Nov 74
CAPPS VICKIE L0001415889-24-026385
SEC(opens sec.gov)
Jun 284
CAPPS VICKIE L0001415889-24-018437
SEC(opens sec.gov)
May 74
CAPPS VICKIE L0000896262-24-000028
SEC(opens sec.gov)
Mar 44
CAPPS VICKIE L0001415889-24-006293
SEC(opens sec.gov)
Sep 54
CAPPS VICKIE L0001209191-23-048177
SEC(opens sec.gov)

Companies

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130